BRAF and colonic neoplasm: In a pooled analysis for patients with stage III colon cancer after curative surgery, Taieb et al. noted that BRAF mutation was associated with a relatively short time to relapse, relatively short survival after relapse, and short OS in patients with microsatellite stable status.